社区
首页
集团介绍
社区
资讯
行情
学堂
TigerAI
登录
注册
奥麦罗制药(OMER)
7.71
+0.06
+0.78%
行情数据延迟15分钟
社区
社区
资讯
资讯
资料
资料
公告
公告
最新
推荐
zeroxu666
·
10-21
$奥麦罗制药(OMER)$
坐等恶魔的低语
$奥麦罗制药(OMER)$ 坐等恶魔的低语
# 晒晒更赚钱
回复
评论
点赞
点赞
编组 21备份 2
分享
举报
复利财神
·
10-15
$奥麦罗制药(OMER)$
一直涨吗 那么厉害啊
$奥麦罗制药(OMER)$ 一直涨吗 那么厉害啊
精彩
zeroxu666:
大佬,你最近很活跃[得意],最近经常看到你,暴涨盘你都在
回复
4
点赞
点赞
编组 21备份 2
分享
举报
Ikoa
·
10-15
$奥麦罗制药(OMER)$
能不能to the moon
$奥麦罗制药(OMER)$ 能不能to the moon
回复
1
点赞
2
编组 21备份 2
分享
举报
Ikoa
·
10-16
$奥麦罗制药(OMER)$
终成正果 给我破!!!
$奥麦罗制药(OMER)$ 终成正果 给我破!!!
回复
评论
点赞
点赞
编组 21备份 2
分享
举报
zeroxu666
·
10-15
$奥麦罗制药(OMER)$
卖盘显著减少
$奥麦罗制药(OMER)$ 卖盘显著减少
回复
评论
点赞
2
编组 21备份 2
分享
举报
27RR
·
04-01
$OMER(OMER)$
财报倒计时!历史财报日股价波动堪比过山车,这次黄标区老司机们安全带系紧没?市场搓手等新药管线进展,稳不稳看这波数据漂移。
$OMER(OMER)$财报倒计时!历史财报日股价波动堪比过山车,这次黄标区老司机们安全带系紧没?市场搓手等新药管线进展,稳不稳看这波数据漂移。
回复
评论
点赞
点赞
编组 21备份 2
分享
举报
sumire521
·
2024-12-19
$奥麦罗制药(OMER)$
沽空时刻!!!
$奥麦罗制药(OMER)$ 沽空时刻!!!
回复
评论
点赞
点赞
编组 21备份 2
分享
举报
Sumire_9572
·
2024-12-19
$奥麦罗制药(OMER)$
沽空时刻!!!
$奥麦罗制药(OMER)$ 沽空时刻!!!
回复
评论
点赞
点赞
编组 21备份 2
分享
举报
zeroxu666
·
2024-12-19
$奥麦罗制药(OMER)$
$奥麦罗制药(OMER)$
# 晒晒更赚钱
回复
评论
点赞
点赞
编组 21备份 2
分享
举报
小虎访谈
·
2024-10-25
【小虎访谈】科迪勒拉:30岁时能买20套深圳房子,炒美股11年挣16倍!生科股有望强劲反弹!
各位虎友们好,本周要与我们分享的虎友是
@科迪勒拉
,在30多岁时,他就实现了财务自由,当时已经可以在深圳买下20多套房子[财迷]!不过,少年得志的他也曾遭遇过挫折,经历了“失去的十年”[流泪]。科迪勒拉认为自己的投资风格与木头姐相似,偏好创新科技领域的投资
$ARK Innovation ETF(ARKK)$
。虽然名气不及她,但从战绩来看,他的表现遥遥领先[强]。在投资美股的11年里,他的收益最高时曾接近40倍,目前回撤到16倍。基于个人经历,他对生物科技股有深入研究。他认为,随着降息周期的到来,小市值生物科技股有望迎来强劲反弹。来吧虎友们,让我们一起来听听他的投资心得大分享吧[你懂的][你懂的]Q: 请简单自我介绍一下(职业、昵称由来、个人闪光点、爱好等)你好虎妞,首先让我表达感谢,感谢你和你们团队对我的认可和支持,没有你们几年前的大V入驻邀请,我也没地方向美股投资人展示自己。我吗?一些虎友尊称为“科兄”,其实,已年过半百,不过,长得还算年轻,心态也不老。我的昵称——科迪勒拉,源于西班牙语,是山脉的意思,也特指位于美洲的世界最长的褶皱山系,这个名字可让人联想起冰川、雪山、森林和矿产资源,有一种刚毅、坚韧、富饶及长远的寓意。我20岁本科毕业,财经专业,在交通部工作2年后,辞职去了深圳,此后一直在金融投资领域工作,现在是一名自由投资人。我似乎谈不上有什么特别的爱好和擅长,如果有的话,就是工作和学习。目前主要从事美国中小市值科技公司的分析、投资。喜欢读哲学、宗教、思想类书籍文章、爱看外星生物等神秘事件有关的,及时政、经济、科普类视频。至于闪光点?如时间退回到20年前,还可以拿出来在年轻人面前显摆
【小虎访谈】科迪勒拉:30岁时能买20套深圳房子,炒美股11年挣16倍!生科股有望强劲反弹!
# 异动频发!你最近错过的机会or意外收获是?
精彩
俺是耕天滴:
答主是传说中的庄家还是默默的股神 ?这种分散化投资小创新股的方法可以复制成功吗?
回复
55
点赞
75
编组 21备份 2
分享
举报
加载更多
公司概况
公司名称
奥麦罗制药
所属市场
NASDAQ
成立日期
- -
员工人数
- -
办公地址
- -
公司网址
http://www.omeros.com
邮政编码
- -
联系电话
- -
联系传真
- -
公司概况
Omeros Corporation在华盛顿成立。该公司正在推进多个开发项目,重点关注与补体系统相关的疾病和紊乱,补体系统是一组专门的蛋白质,可防止侵袭性病原体以及体内受损细胞,是人体免疫系统的重要组成部分。当触发时,补体的各种成分协同产生免疫反应,对抗感染并清除受损或死亡的细胞,维持身体系统的健康功能。然而,补体系统的失调(即过度激活或激活不足)可能是有害的,并且与感染和非感染性疾病的脆弱性增加有关,包括自身免疫性疾病、慢性炎症、血栓性微血管病和癌症。
10-15
重要事件披露
Form 8-K - Current report
Form 8-K - Current report
08-15
季度报告
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08-15
重要事件披露
Form 8-K - Current report
Form 8-K - Current report
07-25
重要事件披露
Form 8-K - Current report
Form 8-K - Current report
07-02
重要事件披露
Form 8-K - Current report
Form 8-K - Current report
05-16
重要事件披露
Form 8-K/A - Current report: [Amend]
Form 8-K/A - Current report: [Amend]
05-16
季度报告
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
05-16
重要事件披露
Form 8-K - Current report
Form 8-K - Current report
05-06
重要事件披露
Form 8-K - Current report
Form 8-K - Current report
04-30
[修订]年度报告
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
03-31
年度报告
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
03-31
重要事件披露
Form 8-K - Current report
Form 8-K - Current report
02-20
重要事件披露
Form 8-K - Current report
Form 8-K - Current report
01-16
重要事件披露
Form 8-K - Current report
Form 8-K - Current report
2024-12-19
重要事件披露
Form 8-K - Current report
Form 8-K - Current report
分时
5日
日
周
月
数据加载中...
最高
7.85
今开
7.70
量比
0.32
最低
7.58
昨收
7.65
换手率
1.44%
热议股票
{"pagemeta":{"title":"奥麦罗制药(OMER)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供奥麦罗制药(OMER)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"奥麦罗制药,OMER,奥麦罗制药股票,奥麦罗制药股票老虎,奥麦罗制药股票老虎国际,奥麦罗制药行情,奥麦罗制药股票行情,奥麦罗制药股价,奥麦罗制药股市,奥麦罗制药股票价格,奥麦罗制药股票交易,奥麦罗制药股票购买,奥麦罗制药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"奥麦罗制药(OMER)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供奥麦罗制药(OMER)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}},"tab":"community","symbol":"OMER","data":{"stockData":{"symbol":"OMER","market":"US","secType":"STK","nameCN":"奥麦罗制药","latestPrice":7.71,"timestamp":1761334041002,"preClose":7.65,"halted":0,"volume":931074,"delay":0,"floatShares":64550800,"shares":68055826,"eps":-2.106341,"marketStatus":"交易中","change":0.06,"latestTime":"10-24 15:27:22 EDT","open":7.7,"high":7.85,"low":7.58,"amount":7197929.188794,"amplitude":0.035294,"askPrice":7.71,"askSize":200,"bidPrice":7.7,"bidSize":372,"shortable":3,"etf":0,"ttmEps":-2.106341,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1761336000000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":1254974400000,"exchange":"NASDAQ","adjPreClose":7.65,"preHourTrading":{"tag":"盘前","latestPrice":7.72,"preClose":7.65,"latestTime":"09:29 EDT","volume":10226,"amount":78195.788212,"timestamp":1761312543878},"postHourTrading":{"tag":"盘后","latestPrice":7.78,"preClose":7.65,"latestTime":"19:45 EDT","volume":14087,"amount":108045.2157,"timestamp":1761263108623},"volumeRatio":0.323117,"impliedVol":1.2487,"impliedVolPercentile":0.768},"tweetData":{"bottom":false,"list":[{"cardType":"TWEET","cardId":"TWEET.491684327866424","cardData":[{"tweetId":"491684327866424","author":{"authorId":"3544572238091832","idStr":"3544572238091832","name":"zeroxu666","avatar":"https://static.laohu8.com/default-avatar.jpg","userType":1,"introduction":"","userGiftHeadFrame":"https://static.tigerbbs.com/0a8758340a08196056f8bc1e54805193","crmLevel":5,"crmLevelSwitch":0,"wearingBadge":{"badgeId":"35ec162348d5460f88c959321e554969-3","templateUuid":"35ec162348d5460f88c959321e554969","name":"Legendary Trader","description":"Total number of securities or futures transactions reached 300","bigImgUrl":"https://static.tigerbbs.com/656db16598a0b8f21429e10d6c1cb033","smallImgUrl":"https://static.tigerbbs.com/03f10910d4dd9234f9b5702a3342193a","grayImgUrl":"https://static.tigerbbs.com/0c767e35268feb729d50d3fa9a386c5a","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":"93.25%","individualDisplayEnabled":0,"individualDisplaySort":0},"individualDisplayBadges":[],"fanSize":64,"starInvestorFlag":false,"userFollowAuthorFlag":false,"authorFollowUserFlag":false},"userFollowAuthorFlag":false,"authorFollowUserFlag":false,"digest":"<a href=\"https://laohu8.com/S/OMER\">$奥麦罗制药(OMER)$</a> 坐等恶魔的低语","plainDigest":"$奥麦罗制药(OMER)$ 坐等恶魔的低语","sourceLanguage":"CN","currentLanguage":"CN","editable":false,"auditStatus":"PASSED","topFlag":false,"totalScore":0,"gmtCreate":1761061304193,"gmtModify":1761061674692,"symbols":["OMER"],"themeIds":["5bfad02ab61749c8bfe6573ac7bbe8a3"],"themes":[{"themeId":"5bfad02ab61749c8bfe6573ac7bbe8a3","themeType":0,"name":"晒晒更赚钱"}],"popularizeThemeFlag":false,"imageCount":1,"images":[{"url":"https://static.tigerbbs.com/1c6921de183f98dfd57c8b81ff460c94","width":"972","height":"1631"}],"repostCount":0,"viewCount":112,"likeCount":0,"liked":false,"collected":false,"commentCount":0,"hotComments":[],"voteFlag":false,"rewardFlag":false,"videoFlag":false,"articleFlag":false,"paperFlag":false,"essentialFlag":false,"highlightedFlag":false,"shareLink":"https://laohu8.com/post/491684327866424","orderFlag":false,"starInvestorRankings":[],"featuresForAnalytics":["晒单贴"],"commentAndTweetFlag":false,"upFlag":false,"length":32,"displayRows":2,"foldSize":0,"authorId":"3544572238091832"}],"position":0},{"cardType":"TWEET","cardId":"TWEET.489497383707400","cardData":[{"tweetId":"489497383707400","author":{"authorId":"3445990815937032","idStr":"3445990815937032","name":"复利财神","avatar":"https://static.tigerbbs.com/3027d52a93306f14ba4547a864966111","userType":1,"introduction":"","crmLevel":7,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":187,"starInvestorFlag":false,"userFollowAuthorFlag":false,"authorFollowUserFlag":false},"userFollowAuthorFlag":false,"authorFollowUserFlag":false,"digest":"<a href=\"https://laohu8.com/S/OMER\">$奥麦罗制药(OMER)$ </a> 一直涨吗 那么厉害啊","plainDigest":"$奥麦罗制药(OMER)$ 一直涨吗 那么厉害啊","sourceLanguage":"CN","currentLanguage":"CN","editable":false,"auditStatus":"PASSED","topFlag":false,"totalScore":0,"gmtCreate":1760533723573,"gmtModify":1760533725328,"symbols":["OMER"],"themeIds":[],"popularizeThemeFlag":false,"imageCount":0,"images":[],"repostCount":0,"viewCount":721,"likeCount":0,"liked":false,"collected":false,"commentCount":4,"hotComments":[{"id":"489499334791272","author":{"authorId":"3544572238091832","idStr":"3544572238091832","name":"zeroxu666","avatar":"https://static.laohu8.com/default-avatar.jpg","userType":1,"introduction":"","userGiftHeadFrame":"https://static.tigerbbs.com/0a8758340a08196056f8bc1e54805193","crmLevel":5,"crmLevelSwitch":0,"fanSize":64,"starInvestorFlag":false},"content":"大佬,你最近很活跃[得意],最近经常看到你,暴涨盘你都在","plainContent":"大佬,你最近很活跃[得意],最近经常看到你,暴涨盘你都在","likeCount":0,"commentType":"hot","coins":0}],"voteFlag":false,"rewardFlag":false,"videoFlag":false,"articleFlag":false,"paperFlag":false,"essentialFlag":false,"highlightedFlag":false,"shareLink":"https://laohu8.com/post/489497383707400","orderFlag":false,"starInvestorRankings":[],"featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":36,"displayRows":2,"foldSize":0,"authorId":"3445990815937032"}],"position":0},{"cardType":"TWEET","cardId":"TWEET.489520875537152","cardData":[{"tweetId":"489520875537152","author":{"authorId":"3577185281557526","idStr":"3577185281557526","name":"Ikoa","avatar":"https://static.tigerbbs.com/b112aec464bc906f291a1f67de8be982","userType":1,"introduction":"","crmLevel":5,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":17,"starInvestorFlag":false,"userFollowAuthorFlag":false,"authorFollowUserFlag":false},"userFollowAuthorFlag":false,"authorFollowUserFlag":false,"digest":"<a href=\"https://laohu8.com/S/OMER\">$奥麦罗制药(OMER)$</a> 能不能to the moon","plainDigest":"$奥麦罗制药(OMER)$ 能不能to the moon","sourceLanguage":"CN","currentLanguage":"CN","editable":false,"auditStatus":"PASSED","topFlag":false,"totalScore":0,"gmtCreate":1760539011948,"gmtModify":1760539013712,"symbols":["OMER"],"themeIds":[],"popularizeThemeFlag":false,"imageCount":0,"images":[],"repostCount":0,"viewCount":574,"likeCount":2,"liked":false,"collected":false,"commentCount":1,"hotComments":[],"voteFlag":false,"rewardFlag":false,"videoFlag":false,"articleFlag":false,"paperFlag":false,"essentialFlag":false,"highlightedFlag":false,"shareLink":"https://laohu8.com/post/489520875537152","orderFlag":false,"starInvestorRankings":[],"featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":33,"displayRows":2,"foldSize":0,"authorId":"3577185281557526"}],"position":0},{"cardType":"TWEET","cardId":"TWEET.489563839393904","cardData":[{"tweetId":"489563839393904","author":{"authorId":"3577185281557526","idStr":"3577185281557526","name":"Ikoa","avatar":"https://static.tigerbbs.com/b112aec464bc906f291a1f67de8be982","userType":1,"introduction":"","crmLevel":5,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":17,"starInvestorFlag":false,"userFollowAuthorFlag":false,"authorFollowUserFlag":false},"userFollowAuthorFlag":false,"authorFollowUserFlag":false,"digest":"<a href=\"https://laohu8.com/S/OMER\">$奥麦罗制药(OMER)$</a> 终成正果 给我破!!!","plainDigest":"$奥麦罗制药(OMER)$ 终成正果 给我破!!!","sourceLanguage":"CN","currentLanguage":"CN","editable":false,"auditStatus":"PASSED","topFlag":false,"totalScore":0,"gmtCreate":1760549869973,"gmtModify":1760549871976,"symbols":["OMER"],"themeIds":[],"popularizeThemeFlag":false,"imageCount":0,"images":[],"repostCount":0,"viewCount":66,"likeCount":0,"liked":false,"collected":false,"commentCount":0,"hotComments":[],"voteFlag":false,"rewardFlag":false,"videoFlag":false,"articleFlag":false,"paperFlag":false,"essentialFlag":false,"highlightedFlag":false,"shareLink":"https://laohu8.com/post/489563839393904","orderFlag":false,"starInvestorRankings":[],"featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":35,"displayRows":2,"foldSize":0,"authorId":"3577185281557526"}],"position":0},{"cardType":"TWEET","cardId":"TWEET.489522730704984","cardData":[{"tweetId":"489522730704984","author":{"authorId":"3544572238091832","idStr":"3544572238091832","name":"zeroxu666","avatar":"https://static.laohu8.com/default-avatar.jpg","userType":1,"introduction":"","userGiftHeadFrame":"https://static.tigerbbs.com/0a8758340a08196056f8bc1e54805193","crmLevel":5,"crmLevelSwitch":0,"wearingBadge":{"badgeId":"35ec162348d5460f88c959321e554969-3","templateUuid":"35ec162348d5460f88c959321e554969","name":"Legendary Trader","description":"Total number of securities or futures transactions reached 300","bigImgUrl":"https://static.tigerbbs.com/656db16598a0b8f21429e10d6c1cb033","smallImgUrl":"https://static.tigerbbs.com/03f10910d4dd9234f9b5702a3342193a","grayImgUrl":"https://static.tigerbbs.com/0c767e35268feb729d50d3fa9a386c5a","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":"93.25%","individualDisplayEnabled":0,"individualDisplaySort":0},"individualDisplayBadges":[],"fanSize":64,"starInvestorFlag":false,"userFollowAuthorFlag":false,"authorFollowUserFlag":false},"userFollowAuthorFlag":false,"authorFollowUserFlag":false,"digest":"<a href=\"https://laohu8.com/S/OMER\">$奥麦罗制药(OMER)$</a> 卖盘显著减少","plainDigest":"$奥麦罗制药(OMER)$ 卖盘显著减少","sourceLanguage":"CN","currentLanguage":"CN","editable":false,"auditStatus":"PASSED","topFlag":false,"totalScore":0,"gmtCreate":1760539315197,"gmtModify":1760539317018,"symbols":["OMER"],"themeIds":[],"popularizeThemeFlag":false,"imageCount":0,"images":[],"repostCount":0,"viewCount":147,"likeCount":2,"liked":false,"collected":false,"commentCount":0,"hotComments":[],"voteFlag":false,"rewardFlag":false,"videoFlag":false,"articleFlag":false,"paperFlag":false,"essentialFlag":false,"highlightedFlag":false,"shareLink":"https://laohu8.com/post/489522730704984","orderFlag":false,"starInvestorRankings":[],"featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":30,"displayRows":2,"foldSize":0,"authorId":"3544572238091832"}],"position":0},{"cardType":"TWEET","cardId":"TWEET.419500859166744","cardData":[{"tweetId":"419500859166744","author":{"authorId":"4182503943177972","idStr":"4182503943177972","name":"27RR","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","userType":1,"introduction":"","crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":49,"starInvestorFlag":false,"userFollowAuthorFlag":false,"authorFollowUserFlag":false},"userFollowAuthorFlag":false,"authorFollowUserFlag":false,"digest":"<a href=\"https://laohu8.com/S/OMER\">$OMER(OMER)$</a>财报倒计时!历史财报日股价波动堪比过山车,这次黄标区老司机们安全带系紧没?市场搓手等新药管线进展,稳不稳看这波数据漂移。","plainDigest":"$OMER(OMER)$财报倒计时!历史财报日股价波动堪比过山车,这次黄标区老司机们安全带系紧没?市场搓手等新药管线进展,稳不稳看这波数据漂移。","sourceLanguage":"CN","currentLanguage":"CN","editable":false,"auditStatus":"PASSED","topFlag":false,"totalScore":0,"gmtCreate":1743448436029,"gmtModify":1743448438607,"symbols":["OMER"],"themeIds":[],"popularizeThemeFlag":false,"imageCount":1,"images":[{"url":"https://static.tigerbbs.com/1fd3c8faebf3222c3c8b2694ee677139","width":"1170","height":"2779"}],"repostCount":0,"viewCount":1135,"likeCount":0,"liked":false,"collected":false,"commentCount":0,"hotComments":[],"voteFlag":false,"rewardFlag":false,"videoFlag":false,"articleFlag":false,"paperFlag":false,"essentialFlag":false,"highlightedFlag":false,"shareLink":"https://laohu8.com/post/419500859166744","orderFlag":false,"starInvestorRankings":[],"featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":127,"displayRows":2,"foldSize":0,"authorId":"4182503943177972"}],"position":0},{"cardType":"TWEET","cardId":"TWEET.383356917977296","cardData":[{"tweetId":"383356917977296","author":{"authorId":"4112853644998230","idStr":"4112853644998230","name":"sumire521","avatar":"https://static.tigerbbs.com/8941bb2990af3611385162a91ef8d7f1","userType":1,"introduction":"","crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":6,"starInvestorFlag":false,"userFollowAuthorFlag":false,"authorFollowUserFlag":false},"userFollowAuthorFlag":false,"authorFollowUserFlag":false,"digest":"<a href=\"https://laohu8.com/S/OMER\">$奥麦罗制药(OMER)$ </a> 沽空时刻!!!","plainDigest":"$奥麦罗制药(OMER)$ 沽空时刻!!!","sourceLanguage":"CN","currentLanguage":"CN","editable":false,"auditStatus":"PASSED","topFlag":false,"totalScore":0,"gmtCreate":1734623257574,"gmtModify":1734623258437,"symbols":["OMER"],"themeIds":[],"popularizeThemeFlag":false,"imageCount":0,"images":[],"repostCount":0,"viewCount":769,"likeCount":0,"liked":false,"collected":false,"commentCount":0,"hotComments":[],"voteFlag":false,"rewardFlag":false,"videoFlag":false,"articleFlag":false,"paperFlag":false,"essentialFlag":false,"highlightedFlag":false,"shareLink":"https://laohu8.com/post/383356917977296","orderFlag":false,"starInvestorRankings":[],"featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":29,"displayRows":2,"foldSize":0,"authorId":"4112853644998230"}],"position":0},{"cardType":"TWEET","cardId":"TWEET.383308614734256","cardData":[{"tweetId":"383308614734256","author":{"authorId":"3514369206910047","idStr":"3514369206910047","name":"Sumire_9572","avatar":"https://static.tigerbbs.com/5e7fbf0b7a1ee37b79a360eb47696d4b","userType":1,"introduction":"","crmLevel":9,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":60,"starInvestorFlag":false,"userFollowAuthorFlag":false,"authorFollowUserFlag":false},"userFollowAuthorFlag":false,"authorFollowUserFlag":false,"digest":"<a href=\"https://laohu8.com/S/OMER\">$奥麦罗制药(OMER)$ </a> 沽空时刻!!!","plainDigest":"$奥麦罗制药(OMER)$ 沽空时刻!!!","sourceLanguage":"CN","currentLanguage":"CN","editable":false,"auditStatus":"PASSED","topFlag":false,"totalScore":0,"gmtCreate":1734622487452,"gmtModify":1734622488675,"symbols":["OMER"],"themeIds":[],"popularizeThemeFlag":false,"imageCount":0,"images":[],"repostCount":0,"viewCount":843,"likeCount":0,"liked":false,"collected":false,"commentCount":0,"hotComments":[],"voteFlag":false,"rewardFlag":false,"videoFlag":false,"articleFlag":false,"paperFlag":false,"essentialFlag":false,"highlightedFlag":false,"shareLink":"https://laohu8.com/post/383308614734256","orderFlag":false,"starInvestorRankings":[],"featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":29,"displayRows":2,"foldSize":0,"authorId":"3514369206910047"}],"position":0},{"cardType":"TWEET","cardId":"TWEET.383306244874768","cardData":[{"tweetId":"383306244874768","author":{"authorId":"3544572238091832","idStr":"3544572238091832","name":"zeroxu666","avatar":"https://static.laohu8.com/default-avatar.jpg","userType":1,"introduction":"","userGiftHeadFrame":"https://static.tigerbbs.com/0a8758340a08196056f8bc1e54805193","crmLevel":5,"crmLevelSwitch":0,"wearingBadge":{"badgeId":"35ec162348d5460f88c959321e554969-3","templateUuid":"35ec162348d5460f88c959321e554969","name":"Legendary Trader","description":"Total number of securities or futures transactions reached 300","bigImgUrl":"https://static.tigerbbs.com/656db16598a0b8f21429e10d6c1cb033","smallImgUrl":"https://static.tigerbbs.com/03f10910d4dd9234f9b5702a3342193a","grayImgUrl":"https://static.tigerbbs.com/0c767e35268feb729d50d3fa9a386c5a","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":"93.25%","individualDisplayEnabled":0,"individualDisplaySort":0},"individualDisplayBadges":[],"fanSize":64,"starInvestorFlag":false,"userFollowAuthorFlag":false,"authorFollowUserFlag":false},"userFollowAuthorFlag":false,"authorFollowUserFlag":false,"digest":"<a href=\"https://laohu8.com/S/OMER\">$奥麦罗制药(OMER)$</a> ","plainDigest":"$奥麦罗制药(OMER)$","sourceLanguage":"EN","currentLanguage":"EN","editable":false,"auditStatus":"PASSED","topFlag":false,"totalScore":0,"gmtCreate":1734621914244,"gmtModify":1734624126197,"symbols":["OMER"],"themeIds":["5bfad02ab61749c8bfe6573ac7bbe8a3"],"themes":[{"themeId":"5bfad02ab61749c8bfe6573ac7bbe8a3","themeType":0,"name":"晒晒更赚钱"}],"popularizeThemeFlag":false,"imageCount":1,"images":[{"url":"https://static.tigerbbs.com/a6c4cc7b3f11999222efb86d9f5a8e24","width":"972","height":"1631"}],"repostCount":0,"viewCount":935,"likeCount":0,"liked":false,"collected":false,"commentCount":0,"hotComments":[],"voteFlag":false,"rewardFlag":false,"videoFlag":false,"articleFlag":false,"paperFlag":false,"essentialFlag":false,"highlightedFlag":false,"shareLink":"https://laohu8.com/post/383306244874768","orderFlag":false,"starInvestorRankings":[],"featuresForAnalytics":["晒单贴"],"commentAndTweetFlag":false,"upFlag":false,"length":18,"displayRows":2,"foldSize":0,"authorId":"3544572238091832"}],"position":0},{"cardType":"TWEET","cardId":"TWEET.363801849651600","cardData":[{"tweetId":"363801849651600","author":{"authorId":"37002306153600","idStr":"37002306153600","name":"小虎访谈","avatar":"https://static.tigerbbs.com/c0f6fba0673df1de1c5c31bb2b4f6d4e","userType":4,"introduction":"老虎国际官方账号","crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":27900,"starInvestorFlag":false,"userFollowAuthorFlag":false,"authorFollowUserFlag":false},"userFollowAuthorFlag":false,"authorFollowUserFlag":false,"title":"【小虎访谈】科迪勒拉:30岁时能买20套深圳房子,炒美股11年挣16倍!生科股有望强劲反弹!","digest":"各位虎友们好,本周要与我们分享的虎友是 <a href=\"https://laohu8.com/U/3484536045691836\">@科迪勒拉</a> ,在30多岁时,他就实现了财务自由,当时已经可以在深圳买下20多套房子[财迷]!不过,少年得志的他也曾遭遇过挫折,经历了“失去的十年”[流泪]。科迪勒拉认为自己的投资风格与木头姐相似,偏好创新科技领域的投资<a href=\"https://laohu8.com/S/ARKK\">$ARK Innovation ETF(ARKK)$</a> 。虽然名气不及她,但从战绩来看,他的表现遥遥领先[强]。在投资美股的11年里,他的收益最高时曾接近40倍,目前回撤到16倍。基于个人经历,他对生物科技股有深入研究。他认为,随着降息周期的到来,小市值生物科技股有望迎来强劲反弹。来吧虎友们,让我们一起来听听他的投资心得大分享吧[你懂的][你懂的]Q: 请简单自我介绍一下(职业、昵称由来、个人闪光点、爱好等)你好虎妞,首先让我表达感谢,感谢你和你们团队对我的认可和支持,没有你们几年前的大V入驻邀请,我也没地方向美股投资人展示自己。我吗?一些虎友尊称为“科兄”,其实,已年过半百,不过,长得还算年轻,心态也不老。我的昵称——科迪勒拉,源于西班牙语,是山脉的意思,也特指位于美洲的世界最长的褶皱山系,这个名字可让人联想起冰川、雪山、森林和矿产资源,有一种刚毅、坚韧、富饶及长远的寓意。我20岁本科毕业,财经专业,在交通部工作2年后,辞职去了深圳,此后一直在金融投资领域工作,现在是一名自由投资人。我似乎谈不上有什么特别的爱好和擅长,如果有的话,就是工作和学习。目前主要从事美国中小市值科技公司的分析、投资。喜欢读哲学、宗教、思想类书籍文章、爱看外星生物等神秘事件有关的,及时政、经济、科普类视频。至于闪光点?如时间退回到20年前,还可以拿出来在年轻人面前显摆","plainDigest":"各位虎友们好,本周要与我们分享的虎友是 @科迪勒拉 ,在30多岁时,他就实现了财务自由,当时已经可以在深圳买下20多套房子[财迷]!不过,少年得志的他也曾遭遇过挫折,经历了“失去的十年”[流泪]。科迪勒拉认为自己的投资风格与木头姐相似,偏好创新科技领域的投资$ARK Innovation ETF(ARKK)$ 。虽然名气不及她,但从战绩来看,他的表现遥遥领先[强]。在投资美股的11年里,他的收益最高时曾接近40倍,目前回撤到16倍。基于个人经历,他对生物科技股有深入研究。他认为,随着降息周期的到来,小市值生物科技股有望迎来强劲反弹。来吧虎友们,让我们一起来听听他的投资心得大分享吧[你懂的][你懂的]Q: 请简单自我介绍一下(职业、昵称由来、个人闪光点、爱好等)你好虎妞,首先让我表达感谢,感谢你和你们团队对我的认可和支持,没有你们几年前的大V入驻邀请,我也没地方向美股投资人展示自己。我吗?一些虎友尊称为“科兄”,其实,已年过半百,不过,长得还算年轻,心态也不老。我的昵称——科迪勒拉,源于西班牙语,是山脉的意思,也特指位于美洲的世界最长的褶皱山系,这个名字可让人联想起冰川、雪山、森林和矿产资源,有一种刚毅、坚韧、富饶及长远的寓意。我20岁本科毕业,财经专业,在交通部工作2年后,辞职去了深圳,此后一直在金融投资领域工作,现在是一名自由投资人。我似乎谈不上有什么特别的爱好和擅长,如果有的话,就是工作和学习。目前主要从事美国中小市值科技公司的分析、投资。喜欢读哲学、宗教、思想类书籍文章、爱看外星生物等神秘事件有关的,及时政、经济、科普类视频。至于闪光点?如时间退回到20年前,还可以拿出来在年轻人面前显摆","sourceLanguage":"CN","currentLanguage":"CN","editable":false,"auditStatus":"PASSED","topFlag":false,"totalScore":0,"gmtCreate":1729844064860,"gmtModify":1730266349044,"symbols":["NVDA","PASG","QS","MRCBF","DBVT","SANA","TMC","JUNO","BNGO","ORGN","OMER","QQQ","BEAM","AUPH","ARVN","TIGR","AMRN","TQQQ","FFIE","VALN","BRK.A","BRK.B","PRVB","ARKK","AXSM","CCXI","VKTX","TSHA","TSLA","NKLA","GWH","NVAX",".IXIC","ACST","CYBN","SAVA","NTLA","GME"],"themeIds":["3d51ef2d90c5494abbe9275c9a7e66fa"],"themes":[{"themeId":"3d51ef2d90c5494abbe9275c9a7e66fa","themeType":0,"name":"异动频发!你最近错过的机会or意外收获是?"}],"popularizeThemeFlag":false,"imageCount":7,"images":[{"url":"https://static.tigerbbs.com/5178b82d3c441ae206a87940f2210d90","width":"696","height":"382"},{"url":"https://static.tigerbbs.com/b1b401b59a699663a48413a35c0871a9","width":"800","height":"432"},{"url":"https://static.tigerbbs.com/e5bd78c087fe3cea04963d06b38a544d","width":"816","height":"943"}],"repostCount":80,"viewCount":61120,"likeCount":75,"liked":false,"collected":false,"commentCount":55,"hotComments":[{"id":"363959014482160","author":{"authorId":"3502783698654092","idStr":"3502783698654092","name":"俺是耕天滴","avatar":"https://static.laohu8.com/default-avatar.jpg","userType":1,"introduction":"","userGiftHeadFrame":"https://static.tigerbbs.com/3b7820dfed76481d8dc4de6ac5a7a136","crmLevel":9,"crmLevelSwitch":1,"fanSize":2,"starInvestorFlag":false},"content":"答主是传说中的庄家还是默默的股神 ?这种分散化投资小创新股的方法可以复制成功吗?","plainContent":"答主是传说中的庄家还是默默的股神 ?这种分散化投资小创新股的方法可以复制成功吗?","likeCount":2,"commentType":"hot","coins":0}],"voteFlag":false,"rewardFlag":false,"videoFlag":false,"articleFlag":false,"paperFlag":true,"essentialFlag":true,"highlightedFlag":true,"shareLink":"https://laohu8.com/post/363801849651600","orderFlag":false,"starInvestorRankings":[],"featuresForAnalytics":[],"commentAndTweetFlag":true,"upFlag":false,"length":12919,"displayRows":2,"foldSize":0,"authorId":"37002306153600"}],"position":0}],"size":10,"extra":{"requestId":"c9f8aba91ac040afac40998e8e6cb5be","feedVerCode":"2"}},"newsData":null,"noticeData":{"listData":[{"cdn_pdf":false,"hasAttachments":true,"id":"20268322","market":"us","labels":[],"media":"sec.gov","original_id":"AN143774925030968-OMER","pdf_url":"","pub_time":1760500800000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"OMER","title":"Form 8-K - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1285819/000143774925030968/0001437749-25-030968-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 1.01: Entry into a Material Definitive Agreement;\nItem 8.01: Other Events;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"EXHIBIT 99.1","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1285819/000143774925030968/ex_870020.htm","primary":true,"translateUrl":"","linkName":"ex_870020.htm","type":"EX-99.1","id":"NTFILEEnYhAcBCgtD2R95i","market":"us","size":23796},{"description":"FORM 8-K","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1285819/000143774925030968/omer20251014_8k.htm","primary":false,"translateUrl":"","linkName":"omer20251014_8k.htm","type":"8-K","id":"NTFILEDKPzo9ELtzGkAMrk","market":"us","size":40006},{"description":"","seq":7,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1285819/000143774925030968/novologo.jpg","primary":false,"translateUrl":"","linkName":"novologo.jpg","type":"GRAPHIC","id":"NTFILEFa2LGKHkdGvFwVqe","market":"us","size":6211},{"description":"","seq":8,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1285819/000143774925030968/omeroslogo.jpg","primary":false,"translateUrl":"","linkName":"omeroslogo.jpg","type":"GRAPHIC","id":"NTFILE2bzDci8nFLnSJj94","market":"us","size":7152},{"description":"","seq":9,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1285819/000143774925030968/pressrelease.jpg","primary":false,"translateUrl":"","linkName":"pressrelease.jpg","type":"GRAPHIC","id":"NTFILE2eWCcLb9cr4DDX1v","market":"us","size":15000}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2025-10-15 12:00","pubTimestamp":1760500800,"title_zh":"Form 8-K - Current report","summary_en":"Item 1.01: Entry into a Material Definitive Agreement;\nItem 8.01: Other Events;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"第1.01项:签订重大最终协议;项目8.01:其他事件;项目9.01:财务报表和附件","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"19991606","market":"us","labels":[],"media":"sec.gov","original_id":"AN143774925026933-OMER","pdf_url":"","pub_time":1755202175000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 10-Q - Quarterly report [Sections 13 or 15(d)]","symbol":"OMER","title":"Form 10-Q - Quarterly report [Sections 13 or 15(d)]","titleType":"季度报告","type":"usFinancials","url":"https://www.sec.gov/Archives/edgar/data/1285819/0001437749-25-026933-index.html","us_notice_code":"Form 10-Q","us_title_en":"Form 10-Q - Quarterly report [Sections 13 or 15(d)]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"FORM 10-Q","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1285819/000143774925026933/omer20250630_10q.htm","primary":true,"translateUrl":"","linkName":"omer20250630_10q.htm","type":"10-Q","id":"NTFILEGrBSxhLXrL7QbDUH","market":"us","size":1554306},{"description":"EXHIBIT 31.1","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1285819/000143774925026933/ex_822300.htm","primary":false,"translateUrl":"","linkName":"ex_822300.htm","type":"EX-31.1","id":"NTFILECmkyCfhxwqzxZzhf","market":"us","size":12796},{"description":"EXHIBIT 31.2","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1285819/000143774925026933/ex_822301.htm","primary":false,"translateUrl":"","linkName":"ex_822301.htm","type":"EX-31.2","id":"NTFILEBQZSRaBdUBojjwLz","market":"us","size":13454},{"description":"EXHIBIT 32.1","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1285819/000143774925026933/ex_822302.htm","primary":false,"translateUrl":"","linkName":"ex_822302.htm","type":"EX-32.1","id":"NTFILEGoW17AGYYjj1bbha","market":"us","size":6502},{"description":"EXHIBIT 32.2","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1285819/000143774925026933/ex_822303.htm","primary":false,"translateUrl":"","linkName":"ex_822303.htm","type":"EX-32.2","id":"NTFILEE5rgjRkQXM7DMGzR","market":"us","size":6523}],"type_name":"财务报告","type_name_en":"Financial Report","titleTypeEn":"Quarterly Report","us_type":"usFinancials","us_type_zh":"财务报告","earn_infos":[],"event_type":"important_notice","event_name":"季度报告","pubTime":"2025-08-15 04:09","pubTimestamp":1755202175,"title_zh":"Form 10-Q - Quarterly report [Sections 13 or 15(d","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"19991510","market":"us","labels":[],"media":"sec.gov","original_id":"AN143774925026931-OMER","pdf_url":"","pub_time":1755201985000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"OMER","title":"Form 8-K - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1285819/0001437749-25-026931-index.html","us_notice_code":"Form 8-K","us_title_en":"Item 2.02: Results of Operations and Financial Condition;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"EXHIBIT 99.1","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1285819/000143774925026931/ex_822292.htm","primary":true,"translateUrl":"","linkName":"ex_822292.htm","type":"EX-99.1","id":"NTFILE6QDXvREvPDokf9hm","market":"us","size":156720},{"description":"FORM 8-K","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1285819/000143774925026931/omer20250521_8k.htm","primary":false,"translateUrl":"","linkName":"omer20250521_8k.htm","type":"8-K","id":"NTFILEDniaCpMVhhhbp5Yz","market":"us","size":26290},{"description":"","seq":7,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1285819/000143774925026931/logo.jpg","primary":false,"translateUrl":"","linkName":"logo.jpg","type":"GRAPHIC","id":"NTFILE6RvSp7NN8VTjvJN6","market":"us","size":5215}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2025-08-15 04:06","pubTimestamp":1755201985,"title_zh":"Form 8-K - Current report","summary_en":"Item 2.02: Results of Operations and Financial Condition;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"项目2.02:经营业绩和财务状况;项目9.01:财务报表和附件","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"19912245","market":"us","labels":[],"media":"sec.gov","original_id":"AN110465925070554-OMER","pdf_url":"","pub_time":1753416000000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"OMER","title":"Form 8-K - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1285819/000110465925070554/0001104659-25-070554-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 8.01: Other Events;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"EXHIBIT 5.1","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1285819/000110465925070554/tm2516030d4_ex5-1.htm","primary":true,"translateUrl":"","linkName":"tm2516030d4_ex5-1.htm","type":"EX-5.1","id":"NTFILECNm3SonGdKukA6KN","market":"us","size":18119},{"description":"FORM 8-K","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1285819/000110465925070554/tm2516030d4_8k.htm","primary":false,"translateUrl":"","linkName":"tm2516030d4_8k.htm","type":"8-K","id":"NTFILEFauXg1crcKi3WVgC","market":"us","size":45187},{"description":"EXHIBIT 10.1","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1285819/000110465925070554/tm2516030d4_ex10-1.htm","primary":false,"translateUrl":"","linkName":"tm2516030d4_ex10-1.htm","type":"EX-10.1","id":"NTFILE2qizLNe82JT3SETV","market":"us","size":167051},{"description":"EXHIBIT 10.2","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1285819/000110465925070554/tm2516030d4_ex10-2.htm","primary":false,"translateUrl":"","linkName":"tm2516030d4_ex10-2.htm","type":"EX-10.2","id":"NTFILE3C7uVh7o5dUKyY23","market":"us","size":68476},{"description":"EXHIBIT 99.1","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1285819/000110465925070554/tm2516030d4_ex99-1.htm","primary":false,"translateUrl":"","linkName":"tm2516030d4_ex99-1.htm","type":"EX-99.1","id":"NTFILEEwo9pv5scU8UG3ca","market":"us","size":10384},{"description":"GRAPHIC","seq":9,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1285819/000110465925070554/tm2516030d4_ex5-1img001.jpg","primary":false,"translateUrl":"","linkName":"tm2516030d4_ex5-1img001.jpg","type":"GRAPHIC","id":"NTFILEHNn534mGhCHrVKBC","market":"us","size":9407},{"description":"GRAPHIC","seq":10,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1285819/000110465925070554/tm2516030d4_ex99-1img001.jpg","primary":false,"translateUrl":"","linkName":"tm2516030d4_ex99-1img001.jpg","type":"GRAPHIC","id":"NTFILE1DR62rYAGSrVN77W","market":"us","size":3619}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2025-07-25 12:00","pubTimestamp":1753416000,"title_zh":"Form 8-K - Current report","summary_en":"Item 8.01: Other Events;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"项目8.01:其他事件;项目9.01:财务报表和附件","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"19840619","market":"us","labels":[],"media":"sec.gov","original_id":"AN143774925021959-OMER","pdf_url":"","pub_time":1751428800000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"OMER","title":"Form 8-K - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1285819/000143774925021959/0001437749-25-021959-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 5.07: Submission of Matters to a Vote of Security Holders","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"FORM 8-K","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1285819/000143774925021959/omer20250624_8k.htm","primary":true,"translateUrl":"","linkName":"omer20250624_8k.htm","type":"8-K","id":"NTFILEEB66ysWNtBwQRGS8","market":"us","size":46995}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2025-07-02 12:00","pubTimestamp":1751428800,"title_zh":"Form 8-K - Current report","summary_en":"Item 5.07: Submission of Matters to a Vote of Security Holders","summary_zh":"项目5.07:将事项提交证券持有人表决","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"19660410","market":"us","labels":[],"media":"sec.gov","original_id":"AN143774925017426-OMER","pdf_url":"","pub_time":1747368000000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K/A - Current report: [Amend]","symbol":"OMER","title":"Form 8-K/A - Current report: [Amend]","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1285819/000143774925017426/0001437749-25-017426-index.htm","us_notice_code":"Form 8-K/A","us_title_en":"Form 8-K/A - Current report: [Amend]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"FORM 8-K/A","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1285819/000143774925017426/omer20250515_8ka.htm","primary":true,"translateUrl":"","linkName":"omer20250515_8ka.htm","type":"8-K/A","id":"NTFILEDC39jMcuvTzcLSh1","market":"us","size":25288},{"description":"EXHIBIT 4.2","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1285819/000143774925017426/ex_819409.htm","primary":false,"translateUrl":"","linkName":"ex_819409.htm","type":"EX-4.2","id":"NTFILE4eaTDFScqZLwyA9j","market":"us","size":782783},{"description":"","seq":7,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1285819/000143774925017426/convrate2.jpg","primary":false,"translateUrl":"","linkName":"convrate2.jpg","type":"GRAPHIC","id":"NTFILE724ozU2trmuYnvTn","market":"us","size":5183},{"description":"","seq":8,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1285819/000143774925017426/convrate3.jpg","primary":false,"translateUrl":"","linkName":"convrate3.jpg","type":"GRAPHIC","id":"NTFILEDokLRtZd7PbTFGLe","market":"us","size":5228},{"description":"","seq":9,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1285819/000143774925017426/convrate4.jpg","primary":false,"translateUrl":"","linkName":"convrate4.jpg","type":"GRAPHIC","id":"NTFILE4pWey16xLtRAmhs4","market":"us","size":5101},{"description":"","seq":10,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1285819/000143774925017426/convrate5.jpg","primary":false,"translateUrl":"","linkName":"convrate5.jpg","type":"GRAPHIC","id":"NTFILECBGF6EDEZggR7PRU","market":"us","size":4451},{"description":"","seq":11,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1285819/000143774925017426/convrate6.jpg","primary":false,"translateUrl":"","linkName":"convrate6.jpg","type":"GRAPHIC","id":"NTFILE5pk3Rv7a9ygbaES4","market":"us","size":7110},{"description":"","seq":12,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1285819/000143774925017426/convrate.jpg","primary":false,"translateUrl":"","linkName":"convrate.jpg","type":"GRAPHIC","id":"NTFILEGTqqSJECmaHCX897","market":"us","size":4671}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2025-05-16 12:00","pubTimestamp":1747368000,"title_zh":"Form 8-K/A - Current report: [Amend","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"19653496","market":"us","labels":[],"media":"sec.gov","original_id":"AN143774925017213-OMER","pdf_url":"","pub_time":1747341171000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 10-Q - Quarterly report [Sections 13 or 15(d)]","symbol":"OMER","title":"Form 10-Q - Quarterly report [Sections 13 or 15(d)]","titleType":"季度报告","type":"usFinancials","url":"https://www.sec.gov/Archives/edgar/data/1285819/0001437749-25-017213-index.html","us_notice_code":"Form 10-Q","us_title_en":"Form 10-Q - Quarterly report [Sections 13 or 15(d)]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"FORM 10-Q","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1285819/000143774925017213/omer20250331_10q.htm","primary":true,"translateUrl":"","linkName":"omer20250331_10q.htm","type":"10-Q","id":"NTFILEDgriH4ZKmVaURe41","market":"us","size":1023860},{"description":"EXHIBIT 31.1","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1285819/000143774925017213/ex_799030.htm","primary":false,"translateUrl":"","linkName":"ex_799030.htm","type":"EX-31.1","id":"NTFILEBAb3LeJ4Yw1KUoDL","market":"us","size":12794},{"description":"EXHIBIT 31.2","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1285819/000143774925017213/ex_799031.htm","primary":false,"translateUrl":"","linkName":"ex_799031.htm","type":"EX-31.2","id":"NTFILEA3RSQjP9zEDuT9EA","market":"us","size":13452},{"description":"EXHIBIT 32.1","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1285819/000143774925017213/ex_799032.htm","primary":false,"translateUrl":"","linkName":"ex_799032.htm","type":"EX-32.1","id":"NTFILE5exwVMYeHHYN5BZp","market":"us","size":6501},{"description":"EXHIBIT 32.2","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1285819/000143774925017213/ex_799033.htm","primary":false,"translateUrl":"","linkName":"ex_799033.htm","type":"EX-32.2","id":"NTFILE9ZpmsvKQeEvK3BGg","market":"us","size":6522}],"type_name":"财务报告","type_name_en":"Financial Report","titleTypeEn":"Quarterly Report","us_type":"usFinancials","us_type_zh":"财务报告","earn_infos":[],"event_type":"important_notice","event_name":"季度报告","pubTime":"2025-05-16 04:32","pubTimestamp":1747341171,"title_zh":"Form 10-Q - Quarterly report [Sections 13 or 15(d","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"19653511","market":"us","labels":[],"media":"sec.gov","original_id":"AN143774925017211-OMER","pdf_url":"","pub_time":1747341070000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"OMER","title":"Form 8-K - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1285819/0001437749-25-017211-index.html","us_notice_code":"Form 8-K","us_title_en":"Item 1.01: Entry into a Material Definitive Agreement;\nItem 2.02: Results of Operations and Financial Condition;\nItem 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant;\nItem 3.02: Unregistered Sales of Equity Securities;\nItem 8.01: Other Events;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"EXHIBIT 4.2","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1285819/000143774925017211/ex_818786.htm","primary":true,"translateUrl":"","linkName":"ex_818786.htm","type":"EX-4.2","id":"NTFILE3BVL3YN17YuUKGz8","market":"us","size":757068},{"description":"FORM 8-K","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1285819/000143774925017211/omer20250407_8k.htm","primary":false,"translateUrl":"","linkName":"omer20250407_8k.htm","type":"8-K","id":"NTFILE2pabuWz1dYxJVgyH","market":"us","size":43522},{"description":"EXHIBIT 10.1","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1285819/000143774925017211/ex_818787.htm","primary":false,"translateUrl":"","linkName":"ex_818787.htm","type":"EX-10.1","id":"NTFILEEKjSodP6cWMa56Ax","market":"us","size":155539},{"description":"EXHIBIT 10.2","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1285819/000143774925017211/ex_818788.htm","primary":false,"translateUrl":"","linkName":"ex_818788.htm","type":"EX-10.2","id":"NTFILE26jZwjuDWpaJxXRG","market":"us","size":88383},{"description":"EXHIBIT 99.1","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1285819/000143774925017211/ex_799147.htm","primary":false,"translateUrl":"","linkName":"ex_799147.htm","type":"EX-99.1","id":"NTFILECp6YtB6tYBmh9oji","market":"us","size":119724},{"description":"EXHIBIT 99.2","seq":6,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1285819/000143774925017211/ex_818789.htm","primary":false,"translateUrl":"","linkName":"ex_818789.htm","type":"EX-99.2","id":"NTFILE5cukwRHa9JnCZDLh","market":"us","size":14636},{"description":"","seq":11,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1285819/000143774925017211/convrate2.jpg","primary":false,"translateUrl":"","linkName":"convrate2.jpg","type":"GRAPHIC","id":"NTFILEBA7M9mfb8Koq5eJs","market":"us","size":5183},{"description":"","seq":12,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1285819/000143774925017211/convrate3.jpg","primary":false,"translateUrl":"","linkName":"convrate3.jpg","type":"GRAPHIC","id":"NTFILEGRZW4tXCJ3thVHLn","market":"us","size":5228},{"description":"","seq":13,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1285819/000143774925017211/convrate4.jpg","primary":false,"translateUrl":"","linkName":"convrate4.jpg","type":"GRAPHIC","id":"NTFILE8dybZFSa33iq6uDK","market":"us","size":5101},{"description":"","seq":14,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1285819/000143774925017211/convrate5.jpg","primary":false,"translateUrl":"","linkName":"convrate5.jpg","type":"GRAPHIC","id":"NTFILE2b5mayeqWykeYDCY","market":"us","size":4451},{"description":"","seq":15,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1285819/000143774925017211/convrate6.jpg","primary":false,"translateUrl":"","linkName":"convrate6.jpg","type":"GRAPHIC","id":"NTFILEDFx6oqdJLNriqHXF","market":"us","size":7110},{"description":"","seq":16,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1285819/000143774925017211/convrate.jpg","primary":false,"translateUrl":"","linkName":"convrate.jpg","type":"GRAPHIC","id":"NTFILEiazR8cdUcmExj2iU","market":"us","size":4671},{"description":"","seq":17,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1285819/000143774925017211/logo.jpg","primary":false,"translateUrl":"","linkName":"logo.jpg","type":"GRAPHIC","id":"NTFILECsxwPGRG9qR3Uw1K","market":"us","size":5215},{"description":"","seq":18,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1285819/000143774925017211/omeroslogo.jpg","primary":false,"translateUrl":"","linkName":"omeroslogo.jpg","type":"GRAPHIC","id":"NTFILE49TMihCDSCuQccpf","market":"us","size":12335}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2025-05-16 04:31","pubTimestamp":1747341070,"title_zh":"Form 8-K - Current report","summary_en":"Item 1.01: Entry into a Material Definitive Agreement;\nItem 2.02: Results of Operations and Financial Condition;\nItem 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant;\nItem 3.02: Unregistered Sales of Equity Securities;\nItem 8.01: Other Events;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"第1.01项:签订重大最终协议;项目2.02:经营业绩和财务状况;第2.03项:直接财务义务或注册人资产负债表外安排下的义务的产生;第3.02项:未经登记的股本证券销售;项目8.01:其他事件;项目9.01:财务报表和附件","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"19605985","market":"us","labels":[],"media":"sec.gov","original_id":"AN143774925014815-OMER","pdf_url":"","pub_time":1746504000000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"OMER","title":"Form 8-K - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1285819/000143774925014815/0001437749-25-014815-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 8.01: Other Events;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"EXHIBIT 99.1","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1285819/000143774925014815/ex_812896.htm","primary":true,"translateUrl":"","linkName":"ex_812896.htm","type":"EX-99.1","id":"NTFILED2ysE7sv8pCoCwbs","market":"us","size":13317},{"description":"FORM 8-K","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1285819/000143774925014815/omer20250506_8k.htm","primary":false,"translateUrl":"","linkName":"omer20250506_8k.htm","type":"8-K","id":"NTFILE9a5qQRHs9sntXe6B","market":"us","size":25292},{"description":"null","seq":7,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1285819/000143774925014815/ex_812896img001.jpg","primary":false,"translateUrl":"","linkName":"ex_812896img001.jpg","type":"GRAPHIC","id":"NTFILEFVDRhkV6eoBRGdnx","market":"us","size":3578}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2025-05-06 12:00","pubTimestamp":1746504000,"title_zh":"Form 8-K - Current report","summary_en":"Item 8.01: Other Events;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"项目8.01:其他事件;项目9.01:财务报表和附件","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"19587999","market":"us","labels":[],"media":"sec.gov","original_id":"AN143774925013902-OMER","pdf_url":"","pub_time":1745985600000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]","symbol":"OMER","title":"Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]","titleType":"[修订]年度报告","type":"usFinancials","url":"https://www.sec.gov/Archives/edgar/data/1285819/000143774925013902/0001437749-25-013902-index.htm","us_notice_code":"Form 10-K/A","us_title_en":"Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"FORM 10-K/A","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1285819/000143774925013902/omer20241231_10ka.htm","primary":true,"translateUrl":"","linkName":"omer20241231_10ka.htm","type":"10-K/A","id":"NTFILEEBuzf7ia1BLUTbHU","market":"us","size":644795},{"description":"EXHIBIT 31.3","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1285819/000143774925013902/ex_804604.htm","primary":false,"translateUrl":"","linkName":"ex_804604.htm","type":"EX-31.3","id":"NTFILED86Ur2WDRcU1q7aD","market":"us","size":3930},{"description":"EXHIBIT 31.4","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1285819/000143774925013902/ex_804621.htm","primary":false,"translateUrl":"","linkName":"ex_804621.htm","type":"EX-31.4","id":"NTFILE7qrZD9mSygwAHYwR","market":"us","size":3665}],"type_name":"财务报告","type_name_en":"Financial Report","titleTypeEn":"[Rev.]Annual Report","us_type":"usFinancials","us_type_zh":"财务报告","earn_infos":[],"event_type":"important_notice","event_name":"[修订]年度报告","pubTime":"2025-04-30 12:00","pubTimestamp":1745985600,"title_zh":"Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"19326904","market":"us","labels":[],"media":"sec.gov","original_id":"AN143774925010216-OMER","pdf_url":"","pub_time":1743393600000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]","symbol":"OMER","title":"Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]","titleType":"年度报告","type":"usFinancials","url":"https://www.sec.gov/Archives/edgar/data/1285819/000143774925010216/0001437749-25-010216-index.htm","us_notice_code":"Form 10-K","us_title_en":"Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"FORM 10-K","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1285819/000143774925010216/omer20241231_10k.htm","primary":true,"translateUrl":"","linkName":"omer20241231_10k.htm","type":"10-K","id":"NTFILEQu3TLFPymV9UysQ7","market":"us","size":1940989},{"description":"EXHIBIT 10.25","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1285819/000143774925010216/ex_769657.htm","primary":false,"translateUrl":"","linkName":"ex_769657.htm","type":"EX-10.25","id":"NTFILE88xiCBCoSq5VZtqq","market":"us","size":38004},{"description":"EXHIBIT 10.30","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1285819/000143774925010216/ex_795700.htm","primary":false,"translateUrl":"","linkName":"ex_795700.htm","type":"EX-10.30","id":"NTFILE8oHWHPfoim44mHt3","market":"us","size":344833},{"description":"EXHIBIT 19.1","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1285819/000143774925010216/ex_769624.htm","primary":false,"translateUrl":"","linkName":"ex_769624.htm","type":"EX-19.1","id":"NTFILE51h3wEQb2ctTBVxU","market":"us","size":115957},{"description":"EXHIBIT 23.1","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1285819/000143774925010216/ex_749884.htm","primary":false,"translateUrl":"","linkName":"ex_749884.htm","type":"EX-23.1","id":"NTFILE6EEsMUSknygSr91i","market":"us","size":7607},{"description":"EXHIBIT 31.1","seq":6,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1285819/000143774925010216/ex_749885.htm","primary":false,"translateUrl":"","linkName":"ex_749885.htm","type":"EX-31.1","id":"NTFILE9YcUnPreBKUbVZ1U","market":"us","size":8760},{"description":"EXHIBIT 31.2","seq":7,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1285819/000143774925010216/ex_749886.htm","primary":false,"translateUrl":"","linkName":"ex_749886.htm","type":"EX-31.2","id":"NTFILEAUDEUpdRukwApffj","market":"us","size":8717},{"description":"EXHIBIT 32.1","seq":8,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1285819/000143774925010216/ex_749887.htm","primary":false,"translateUrl":"","linkName":"ex_749887.htm","type":"EX-32.1","id":"NTFILE4dZBq5LZiwGrj8me","market":"us","size":5372},{"description":"EXHIBIT 32.2","seq":9,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1285819/000143774925010216/ex_749888.htm","primary":false,"translateUrl":"","linkName":"ex_749888.htm","type":"EX-32.2","id":"NTFILE8umL8GGXfgVVUzyb","market":"us","size":5401},{"description":"","seq":15,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1285819/000143774925010216/ex_769657img001.jpg","primary":false,"translateUrl":"","linkName":"ex_769657img001.jpg","type":"GRAPHIC","id":"NTFILE9YGfcKVPvRCwfS7Q","market":"us","size":58395},{"description":"","seq":16,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1285819/000143774925010216/yearcumulativereturn.jpg","primary":false,"translateUrl":"","linkName":"yearcumulativereturn.jpg","type":"GRAPHIC","id":"NTFILE2qaG5xPs3Frc57dF","market":"us","size":28591}],"type_name":"财务报告","type_name_en":"Financial Report","titleTypeEn":"Annual Report","us_type":"usFinancials","us_type_zh":"财务报告","earn_infos":[],"event_type":"important_notice","event_name":"年度报告","pubTime":"2025-03-31 12:00","pubTimestamp":1743393600,"title_zh":"Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"19326892","market":"us","labels":[],"media":"sec.gov","original_id":"AN143774925010211-OMER","pdf_url":"","pub_time":1743393600000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"OMER","title":"Form 8-K - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1285819/000143774925010211/0001437749-25-010211-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 2.02: Results of Operations and Financial Condition;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"EXHIBIT 99.1","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1285819/000143774925010211/ex_749944.htm","primary":true,"translateUrl":"","linkName":"ex_749944.htm","type":"EX-99.1","id":"NTFILE7mVxcQbCio3nGz1T","market":"us","size":154047},{"description":"FORM 8-K","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1285819/000143774925010211/omer20241119_8k.htm","primary":false,"translateUrl":"","linkName":"omer20241119_8k.htm","type":"8-K","id":"NTFILECnZM8bN2hWd2Rptv","market":"us","size":25740},{"description":"","seq":7,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1285819/000143774925010211/logo.jpg","primary":false,"translateUrl":"","linkName":"logo.jpg","type":"GRAPHIC","id":"NTFILE2tKNgXeQTCM3jqXJ","market":"us","size":5215}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2025-03-31 12:00","pubTimestamp":1743393600,"title_zh":"Form 8-K - Current report","summary_en":"Item 2.02: Results of Operations and Financial Condition;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"第2.02项:经营业绩和财务状况;项目9.01:财务报表和附件","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"19128157","market":"us","labels":[],"media":"sec.gov","original_id":"AN143774925004505-OMER","pdf_url":"","pub_time":1740027600000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"OMER","title":"Form 8-K - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1285819/000143774925004505/0001437749-25-004505-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 8.01: Other Events;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"EXHIBIT 99.1","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1285819/000143774925004505/ex_777670.htm","primary":true,"translateUrl":"","linkName":"ex_777670.htm","type":"EX-99.1","id":"NTFILECGqME7vUrdFY73Hd","market":"us","size":37345},{"description":"FORM 8-K","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1285819/000143774925004505/omer20250212_8k.htm","primary":false,"translateUrl":"","linkName":"omer20250212_8k.htm","type":"8-K","id":"NTFILE86fW5453K2y6QvWu","market":"us","size":25337},{"description":"","seq":7,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1285819/000143774925004505/ex_777670img001.jpg","primary":false,"translateUrl":"","linkName":"ex_777670img001.jpg","type":"GRAPHIC","id":"NTFILE3rbaMisiqfqHoPQc","market":"us","size":3578}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2025-02-20 13:00","pubTimestamp":1740027600,"title_zh":"Form 8-K - Current report","summary_en":"Item 8.01: Other Events;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"项目8.01:其他事件;项目9.01:财务报表和附件","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"19048777","market":"us","labels":[],"media":"sec.gov","original_id":"AN143774925001245-OMER","pdf_url":"","pub_time":1737003600000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"OMER","title":"Form 8-K - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1285819/000143774925001245/0001437749-25-001245-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 8.01: Other Events;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"EXHIBIT 99.1","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1285819/000143774925001245/ex_766537.htm","primary":true,"translateUrl":"","linkName":"ex_766537.htm","type":"EX-99.1","id":"NTFILE5CSwE39ixR7xwKbY","market":"us","size":26777},{"description":"FORM 8-K","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1285819/000143774925001245/omer20250116c_8k.htm","primary":false,"translateUrl":"","linkName":"omer20250116c_8k.htm","type":"8-K","id":"NTFILE2xdAsfBhnkCXS5DZ","market":"us","size":25258},{"description":"","seq":7,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1285819/000143774925001245/ex_766537img001.jpg","primary":false,"translateUrl":"","linkName":"ex_766537img001.jpg","type":"GRAPHIC","id":"NTFILE2FnxF4EnvSf3rNv6","market":"us","size":3578}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2025-01-16 13:00","pubTimestamp":1737003600,"title_zh":"Form 8-K - Current report","summary_en":"Item 8.01: Other Events;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"项目8.01:其他事件;项目9.01:财务报表和附件","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"18961656","market":"us","labels":[],"media":"sec.gov","original_id":"AN143774924037898-OMER","pdf_url":"","pub_time":1734584400000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"OMER","title":"Form 8-K - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1285819/000143774924037898/0001437749-24-037898-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 8.01: Other Events;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"EXHIBIT 99.1","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1285819/000143774924037898/ex_755914.htm","primary":true,"translateUrl":"","linkName":"ex_755914.htm","type":"EX-99.1","id":"NTFILE4JBtHNGupRWYqG43","market":"us","size":22381},{"description":"FORM 8-K","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1285819/000143774924037898/omer20241210_8k.htm","primary":false,"translateUrl":"","linkName":"omer20241210_8k.htm","type":"8-K","id":"NTFILE4bEckRcW5c99cxRB","market":"us","size":24257},{"description":"","seq":7,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1285819/000143774924037898/ex_755914img001.jpg","primary":false,"translateUrl":"","linkName":"ex_755914img001.jpg","type":"GRAPHIC","id":"NTFILEGCrpYnYziRRew6Pa","market":"us","size":3578}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2024-12-19 13:00","pubTimestamp":1734584400,"title_zh":"Form 8-K - Current report","summary_en":"Item 8.01: Other Events;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"项目8.01:其他事件;项目9.01:财务报表和附件","notice_type":"","filling_tag":"","gpt_icon":0}],"currentPage":1,"bottom":false},"companyData":{"profile":{"websiteUrl":"http://www.omeros.com","stockEarnings":[{"period":"1week","weight":-0.2218},{"period":"1month","weight":0.7874},{"period":"3month","weight":0.9974},{"period":"6month","weight":0.0465},{"period":"1year","weight":0.8523},{"period":"ytd","weight":-0.2257}],"compareEarnings":[{"period":"1week","weight":0.0168},{"period":"1month","weight":0.0129},{"period":"3month","weight":0.0544},{"period":"6month","weight":0.22},{"period":"1year","weight":0.1622},{"period":"ytd","weight":0.1462}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Omeros Corporation在华盛顿成立。该公司正在推进多个开发项目,重点关注与补体系统相关的疾病和紊乱,补体系统是一组专门的蛋白质,可防止侵袭性病原体以及体内受损细胞,是人体免疫系统的重要组成部分。当触发时,补体的各种成分协同产生免疫反应,对抗感染并清除受损或死亡的细胞,维持身体系统的健康功能。然而,补体系统的失调(即过度激活或激活不足)可能是有害的,并且与感染和非感染性疾病的脆弱性增加有关,包括自身免疫性疾病、慢性炎症、血栓性微血管病和癌症。","yearOnYearQuotes":[{"month":1,"riseRate":0.375,"avgChangeRate":0.006425},{"month":2,"riseRate":0.5625,"avgChangeRate":0.058594},{"month":3,"riseRate":0.625,"avgChangeRate":0.097428},{"month":4,"riseRate":0.375,"avgChangeRate":-0.031657},{"month":5,"riseRate":0.375,"avgChangeRate":-0.032445},{"month":6,"riseRate":0.3125,"avgChangeRate":0.036171},{"month":7,"riseRate":0.4375,"avgChangeRate":0.065457},{"month":8,"riseRate":0.3125,"avgChangeRate":-0.029297},{"month":9,"riseRate":0.3125,"avgChangeRate":-0.001727},{"month":10,"riseRate":0.5,"avgChangeRate":-0.037176},{"month":11,"riseRate":0.625,"avgChangeRate":0.230689},{"month":12,"riseRate":0.5,"avgChangeRate":0.021535}],"exchange":"NASDAQ","name":"奥麦罗制药","nameEN":"Omeros"},"aProfile":null}}}